Biotika a.s.

BSSE-1BSL01AE
Bratislava Stock Exchange
Healthcare Pharmaceutical Preparations
Global Rank
#42583
Country Rank
#6
Market Cap
7.37 M
Price
10.48
Change (%)
0.00%
Volume
86

Biotika a.s.'s latest marketcap:

7.37 M

As of 08/19/2025, Biotika a.s.'s market capitalization has reached $7.37 M. According to our data, Biotika a.s. is the 42583th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 7.37 M
Revenue (ttm) 13.39 M
Net Income (ttm) -1,456,162.63
Shares Out 700,000
EPS (ttm) -2.08
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 08/19/2025

Biotika a.s.'s yearly market capitalization.

Biotika a.s. has seen its market value drop from €30.27 M to €6.3 M since 2020, representing a total decrease of 79.19% and an annual compound decline rate (CAGR) of 28.72%.
Date Market Cap(€) Market Cap(USD) Change (%) Global Rank
08/19/2025 €6.3 M $7.37 M -40% 42583
12/18/2024 €10.5 M $10.87 M -51.01% n/a
12/11/2023 €21.43 M $23.66 M -5.22% n/a
12/12/2022 €22.61 M $24.2 M -42.5% n/a
12/27/2021 €39.33 M $44.7 M 29.94% n/a
12/30/2020 €30.27 M $36.97 M n/a

Company Profile

Biotika a.s. operates as a pharmaceutical manufacturing company in Slovakia and internationally.

The company offers active pharmaceutical ingredients (API), including phenoxymethylpenicillin calcium, phenoxymethylpenicillin potassium, phenoxymethylpenicillin potassium granulated, and polymyxin B sulfate (non-sterile) substances; and pharmaceutical preparations for the human and veterinary applications.

It is also involved in the contract manufacture of APIs comprising Gramicidin S hydrochlorid (non-sterile) and L-CYSTINE substances; and antibiotics.

In addition, the company produces and sells cosmetic products feed additives, disinfectants and organic chemicals, composts and organic fertilizers, and medical devices, as well as food products, such as drinks, protein substances, and related derivatives.

Further, it provides waste water treatment and cooling water diversion services, as well as various services in the waste management sector; freight road transportation services; and rental services.

Additionally, the company engages in the research and development of natural and technical sciences; and operation of railway track.

Biotika a.s. was founded in 1953 and is headquartered in Slovenská Lupca, Slovakia.

Frequently Asked Questions

  • What is Biotika a.s.'s (BSSE-1BSL01AE) current market cap?
    As of 08/19/2025, Biotika a.s. (including the parent company, if applicable) has an estimated market capitalization of $7.37 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Biotika a.s. global market capitalization ranking is approximately 42583 as of 08/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.